fashion -WSS

fashion

author：explore 2025-09-02 22:00:15 - browse：78733

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Health care court cases: Humana, Sutter, Novant

explore

WSS

Readout Newsletter: XBI biotech index, Akero Therapeutics

Readout Newsletter: XBI biotech index, Akero Therapeutics

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Cigna wins case to block Amy Bricker's move to CVS

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Curing rare childhood diseases will falter unless Congress steps up

Wikipedia

fashion

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Pharma companies must ensure equitable access to obesity drugs

Medical records are filled with copy

NIH tests clinical research in primary care with $30 million program

As demand for Covid shots wanes, Moderna seeks its next success

Readers discuss the intersection of pregnancy and addiction

Apple is now the first public company to be valued at $3 trillion

Traditional Chinese medicine benefits explored in new JAMA study

Cancer drug shortages should be causing more outrage

FDA has safety concerns on CRISPR

knowledge

Telehealth options flood the market as retailers push virtual care

Health care court cases: Humana, Sutter, Novant

Report captures long Covid’s disabling effects and policy challenges

Pharma companies must ensure equitable access to obesity drugs

Diversifying clinical trials isn't enough to close racial gaps: study

Hospitals warn Medicare's drug payment fix is ‘unlawful’

explore

explore

focus

leisure time